Pricing Log in Create free account

Precipio, Inc. (PRPO) vs XWELL, Inc. (XWEL)

Precipio, Inc. and XWELL, Inc. are both Diagnostics & Research companies. Precipio, Inc. is the larger, with a market value of $33.3M against $6.1M — 5.5× the size. Precipio, Inc. grew revenue faster over the last twelve months: 28.0% against −7.58%. Precipio, Inc. has the higher net margin (−4.47% vs −117.8%) and the lower return on invested capital (−7.63% vs 0.00%). Across the 19 metrics below, Precipio, Inc. leads on 12 and XWELL, Inc. on 7.

Valuation

Metric PRPO XWEL Diagnostics & Research median
P/E n/m n/m 34.52
P/S 1.25 0.17 4.24
P/B 2.30 0.59 3.42
Price to free cash flow 43.09 n/m 33.51
EV/EBITDA 107.75 0.12 23.44
EV/Sales 1.17 (0.06) 5.18
Earnings yield (3.36%) (933.33%) (1.50%)
Free cash flow yield 2.32% (278.57%) 0.00%

Profitability

Metric PRPO XWEL Diagnostics & Research median
Gross margin 44.11% 34.34% 48.32%
Operating margin (5.68%) (61.31%) (5.68%)
Net margin (4.47%) (117.83%) (4.10%)
Free cash flow margin 2.90% (47.65%) 0.00%
Return on equity (8.98%) (557.21%) 0.00%
Return on assets (6.05%) (155.10%) (6.05%)
Return on invested capital (7.63%) 0.00% 0.00%

Growth

Metric PRPO XWEL Diagnostics & Research median
Revenue growth (TTM) 28.04% (7.58%) 8.99%
EPS growth (last fiscal year) 92.15% (38.80%) 20.36%
Revenue growth, 5-year CAGR 31.60% 28.35% 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PRPO XWEL Diagnostics & Research median
Debt to equity 0.07 0.00 0.01
Current ratio 1.77 2.27 2.27
Net debt to EBITDA (3.30) (0.08) 0.68

Dividend

Metric PRPO XWEL Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric PRPO XWEL Diagnostics & Research median
Market cap 33.28m 6.08m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack